Tabuchi et al., 2002 - Google Patents
REST4-mediated modulation of REST/NRSF-silencing function during BDNF gene promoter activationTabuchi et al., 2002
- Document ID
- 13734155546066326550
- Author
- Tabuchi A
- Yamada T
- Sasagawa S
- Naruse Y
- Mori N
- Tsuda M
- Publication year
- Publication venue
- Biochemical and biophysical research communications
External Links
Snippet
Neural-restrictive silencer element (NRSE)/repressor element-1 (RE1) regulates neuron- specific gene expression by binding the transcriptional factor REST/NRSF which functions as a silencer in nonneuronal cells. In neuronal cells, a truncated, neuronal-specific …
- 230000004913 activation 0 title abstract description 28
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tabuchi et al. | REST4-mediated modulation of REST/NRSF-silencing function during BDNF gene promoter activation | |
Jin et al. | Activation of proglucagon gene transcription through a novel promoter element by the caudal-related homeodomain protein cdx-2/3 | |
Scarpulla | Nuclear control of respiratory chain expression in mammalian cells | |
Cambi et al. | 5′ Flanking DNA sequences direct cell‐specific expression of rat tyrosine hydroxylase | |
Kraner et al. | Silencing the type II sodium channel gene: a model for neural-specific gene regulation | |
Chien et al. | Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response | |
Yuan et al. | Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. | |
Zhang et al. | The Drosophila homolog of mammalian zinc finger factor MTF-1 activates transcription in response to heavy metals | |
Hasegawa et al. | cis-Acting sequences that mediate induction of β-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction | |
Galvagni et al. | Sp1 and Sp3 physically interact and co-operate with GABP for the activation of the utrophin promoter | |
Peralta et al. | Mitochondrial transcription: lessons from mouse models | |
Leenders et al. | Repression of cardiac hypertrophy by KLF15: underlying mechanisms and therapeutic implications | |
Wang et al. | TRIM45, a novel human RBCC/TRIM protein, inhibits transcriptional activities of ElK-1 and AP-1 | |
Benkhelifa et al. | mafA, a novel member of the maf proto-oncogene family, displays developmental regulation and mitogenic capacity in avian neuroretina cells | |
Moffett et al. | Transcriptional regulation of fibroblast growth factor-2 expression in human astrocytes: implications for cell plasticity | |
Zelzer et al. | Interaction between the bHLH-PAS protein Trachealess and the POU-domain protein Drifter, specifies tracheal cell fates | |
Lietz et al. | RE‐1 silencing transcription factor (REST) regulates human synaptophysin gene transcription through an intronic sequence‐specific DNA‐binding site | |
Tabuchi | Synaptic plasticity-regulated gene expression: a key event in the long-lasting changes of neuronal function | |
Watanabe et al. | Regulatory mechanisms of cAMP‐dependent and cell‐specific expression of human steroidogenic cytochrome P450scc (CYP11A1) gene | |
Alexander‐Bridges et al. | Identification of a core motif that is recognized by three members of the HMG class of transcriptional regulators: IRE‐ABP, SRY, and TCF‐1α | |
Henderson et al. | c-Jun inhibits transcriptional activation by the insulin enhancer, and the insulin control element is the target of control | |
AU5542799A (en) | Growth differentiation factor promoter and uses therefor | |
Okamoto et al. | Absence of binding activity of neuron-restrictive silencer factor is necessary, but not sufficient for transcription of NMDA receptor subunit type 1 in neuronal cells | |
Marini et al. | Cloning MafF by recognition site screening with the NFE2 tandem repeat of HS2: analysis of its role in globin and GCSl genes regulation | |
Robert et al. | Synergistic activation of the human choline acetyltransferase gene by c-Myb and C/EBPβ |